Solace Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.20 Cr
- Satisfied Charges ₹ 5.61 Cr
- Revenue Growth -27.00%
- Profit Growth -48.89%
- Ebitda 13.54%
- Net Worth 1.83%
- Total Assets 2.37%
About Solace Biotech
Solace Biotech Limited (SBL) is a leading Public Limited Indian Non-Government Company incorporated in India on 22 July 2013 and has a history of 11 years and six months. Its registered office is in Ambala, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹5.20 Cr. The company has closed loans amounting to ₹5.61 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kamal Chawla, Raman Chawla, and Rohit Gupta serve as directors at the Company.
Company Details
-
Location
Ambala, Haryana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24232HR2013PLC049887
-
Company No.
049887
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
22 Jul 2013
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Solace Biotech Limited offer?
Solace Biotech Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Pharmaceutical Medicine, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Pharmaceutical Tablets, Packaging Caps & Seals, Cap Closures, Antibiotic Injection, Corporate & Business Gifts.
Who are the key members and board of directors at Solace Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Gupta
|
Director | 24-Dec-2022 | Current |
|
Kamal Chawla
|
Director | 22-Jul-2013 | Current |
|
Raman Chawla
|
Director | 22-Jul-2013 | Current |
Financial Performance of Solace Biotech.
Solace Biotech Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 27% decrease. The company also saw a substantial fall in profitability, with a 48.89% decrease in profit. The company's net worth moved up by a moderate rise of 1.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Solace Biotech?
In 2023, Solace Biotech had a promoter holding of 99.77% and a public holding of 0.23%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹51.95 M
₹56.08 M
Charges Breakdown by Lending Institutions
- Others : 5.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Dec 2022 | Others | ₹3.70 Cr | Open |
| 22 Dec 2022 | Others | ₹2.62 M | Open |
| 22 Dec 2022 | Others | ₹1.75 M | Open |
| 22 Dec 2022 | Others | ₹3.20 M | Open |
| 07 May 2019 | Others | ₹3.16 M | Open |
How Many Employees Work at Solace Biotech?
Solace Biotech has a workforce of 10 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Solace Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solace Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
